Literature DB >> 2303246

Haplotyping of the human porphobilinogen deaminase gene in acute intermittent porphyria by polymerase chain reaction.

J S Lee1, J Lindsten, M Anvret.   

Abstract

Acute intermittent porphyria (AIP) is due to a defect in porphobilinogen deaminase (PBGD, E.C. 4.1.3.8) inherited as an autosomal dominant trait. Presymptomatic carrier detection is important in order to avoid exposure to factors inducing severe clinical symptoms. Carriers and noncarriers of the AIP gene can be distinguished by linkage analysis using three intragenic RFLPs in AIP families. In the present study, the polymerase chain reaction (PCR) was used to amplify 3.3-kb genomic sequences covering three polymorphic sites. Haplotypes were identified after cleavage of amplified products with three restriction enzymes, showing that the technique can be successfully used for linkage analysis in AIP families.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303246     DOI: 10.1007/bf00200567

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A.

Authors:  S C Kogan; M Doherty; J Gitschier
Journal:  N Engl J Med       Date:  1987-10-15       Impact factor: 91.245

3.  The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.

Authors:  K Miyagi; R Cardinal; I Bossenmaier; C J Watson
Journal:  J Lab Clin Med       Date:  1971-11

4.  Simple non-invasive method to obtain DNA for gene analysis.

Authors:  N Lench; P Stanier; R Williamson
Journal:  Lancet       Date:  1988-06-18       Impact factor: 79.321

5.  A PstI polymorphism for the human porphobilinogen deaminase gene (PBG).

Authors:  J S Lee; M Anvret
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

6.  Tissue-specific splicing mutation in acute intermittent porphyria.

Authors:  B Grandchamp; C Picat; V Mignotte; J H Wilson; K Te Velde; L Sandkuyl; P H Roméo; M Goossens; Y Nordmann
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.

Authors:  L J Strand; U A Meyer; B F Felsher; A G Redeker; H S Marver
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  DNA polymorphism of human porphobilinogen deaminase gene in acute intermittent porphyria.

Authors:  D H Llewellyn; G H Elder; N A Kalsheker; O W Marsh; P R Harrison; B Grandchamp; C Picat; Y Nordmann; P H Romeo; M Goossens
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

9.  Molecular cloning and complete primary sequence of human erythrocyte porphobilinogen deaminase.

Authors:  N Raich; P H Romeo; A Dubart; D Beaupain; M Cohen-Solal; M Goossens
Journal:  Nucleic Acids Res       Date:  1986-08-11       Impact factor: 16.971

10.  Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.

Authors:  S Sassa; G Solish; R D Levere; A Kappas
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  5 in total

1.  Genetic heterogeneity of the porphobilinogen deaminase gene in Swedish families with acute intermittent porphyria.

Authors:  J S Lee; G Lundin; L Lannfelt; L Forsell; C Picat; B Grandchamp; M Anvret
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.

Authors:  C H Chen; K H Astrin; G Lee; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 3.  Porphobilinogen deaminase gene structure and molecular defects.

Authors:  J C Deybach; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

4.  Two new mutations in the porphobilinogen deaminase gene and a screening method using PCR amplification of specific alleles.

Authors:  G Lundin; A Wedell; S Thunell; M Anvret
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

5.  Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria.

Authors:  J S Lee; M Anvret
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.